NDC 0074-1040 – Survanta

Beractant 25 mg/mL · Suspension · Endotracheal

Human Prescription Drug

Product NDC0074-1040

Product details

Brand name
Survanta
Generic name
Beractant
Labeler
AbbVie Inc.
Dosage form
Suspension
Route
Endotracheal
Marketing category
BLA · BLA020032
Marketed since
July 1, 1991
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Survanta →

Package NDC codes (2)

Package NDCDescriptionSince
0074-1040-041 VIAL, SINGLE-USE in 1 CARTON (0074-1040-04) / 4 mL in 1 VIAL, SINGLE-USEJul 1, 1991
0074-1040-081 VIAL, SINGLE-USE in 1 CARTON (0074-1040-08) / 8 mL in 1 VIAL, SINGLE-USEJul 1, 1991